Baolingbao Biology Co.,Ltd. (SHE:002286)
China · Delayed Price · Currency is CNY 8.09
+0.07 (0.87%)
Jul 15, 2026, 3:04 PM CST
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.05 billion as of July 15, 2026. Its market cap has decreased by -24.48% in one year.
Market Cap
3.05B
Enterprise Value
3.00B
Revenue
2.81B
Ranking
n/a
PE Ratio
19.43
Stock Price
8.09
Market Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.05B, an increase of 68.94%. That is a compound annual growth rate of 3.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 3.05B | -10.29% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assure Tech (Hangzhou) | 3.60B |
| Pulike Biological Engineering | 3.57B |
| Hubei Goto Biopharm Group | 3.27B |
| Qingdao Vland Biotech INC. | 3.07B |
| Guanhao Biotech | 3.06B |
| Beijing Kawin Technology Share-Holding | 2.88B |
| Zhejiang Shouxiangu Pharmaceutical | 2.87B |
| Guangdong VTR Bio-Tech | 2.86B |